BPG is committed to discovery and dissemination of knowledge
Featured Articles
8/26/2019 8:12:04 AM | Browse: 700 | Download: 1269
Publication Name World Journal of Clinical Cases
Manuscript ID 49190
Country China
Received
2019-05-18 05:32
Peer-Review Started
2019-05-18 06:19
First Decision by Editorial Office Director
2019-06-09 00:34
Return for Revision
2019-06-11 08:58
Revised
2019-06-21 16:21
Publication Fee Transferred
Second Decision by Editor
2019-07-12 09:55
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2019-07-20 04:10
Articles in Press
2019-07-20 04:10
Edit the Manuscript by Language Editor
2019-08-09 18:16
Typeset the Manuscript
2019-08-23 06:57
Publish the Manuscript Online
2019-08-26 02:56
ISSN 2307-8960 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Minireviews
Article Title Application of Newcastle disease virus in the treatment of colorectal cancer
Manuscript Source Unsolicited Manuscript
All Author List Hui Song, Li-Ping Zhong, Jian He, Yong Huang and Yong-Xiang Zhao
Funding Agency and Grant Number
Corresponding Author Yong-Xiang Zhao, MD, PhD, Professor, National Center for International Research of Bio-targeting Theranostics, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, Guangxi Medical University, Nanning 530021, Guangxi Zhuang Autonomous Region, China. yongxiang_zhao@126.com
Key Words Newcastle disease virus; Exogenous gene; Armed virus; Oncolytic therapy; Colorectal cancer;
Core Tip At present, the main treatment for colorectal cancer (CRC) are surgical treatment and chemotherapy, but the majority of patients die due to liver or lung metastasis or recurrence. Therefore, there is an urgent need to find more effective treatment strategies to reduce their mortality. Newcastle disease virus (NDV) can selectively infect tumor cells, and can also improve the ability of NDV to resist CRC by constructing an autologous tumor vaccine (ATV-NDV). The series clinical treatment tests have also proved its good therapeutic effect, and it is hopeful to become a new treatment for CRC.
Publish Date 2019-08-26 02:56
Citation Song H, Zhong LP, He J, Huang Y, Zhao YX. Application of Newcastle disease virus in the treatment of colorectal cancer. World J Clin Cases 2019; 2143-2154
URL https://www.wjgnet.com/2307-8960/full/v7/i16/2143.htm
DOI https://dx.doi.org/10.12998/wjcc.v7.i16.2143
Full Article (PDF) WJCC-7-2143.pdf
Full Article (Word) WJCC-7-2143.docx